{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:33:56Z","timestamp":1794047636987,"version":"4.8.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41579-020-0353-8","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T15:07:07Z","timestamp":1587049627000},"page":"261-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Turning the tide: targeting PfCRT to combat drug-resistant P. falciparum?"],"prefix":"10.1038","volume":"18","author":[{"given":"Jennifer L.","family":"Small-Saunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Hagenah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"353_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm, R. W. et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect. Dis. 19, 952\u2013961 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"17050","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Primers 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00018-011-0906-0","volume":"69","author":"RL Summers","year":"2012","unstructured":"Summers, R. L., Nash, M. N. & Martin, R. E. Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics. Cell. Mol. Life Sci. 69, 1967\u20131995 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"353_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05652-0","volume":"9","author":"LS Ross","year":"2018","unstructured":"Ross, L. S. et al. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine. Nat. Commun. 9, 3314 (2018).","journal-title":"Nat. Commun."},{"key":"353_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","volume":"576","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT. Nature 576, 315\u2013320 (2019).","journal-title":"Nature"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/acsinfecdis.7b00217","volume":"4","author":"LS Ross","year":"2018","unstructured":"Ross, L. S. et al. Identification of collateral sensitivity to dihydroorotate dehydrogenase Inhibitors in Plasmodium falciparum. ACS Infect. Dis. 4, 508\u2013515 (2018).","journal-title":"ACS Infect. Dis."},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"e01913","DOI":"10.1128\/AAC.01913-16","volume":"61","author":"B Gunsaru","year":"2017","unstructured":"Gunsaru, B. et al. Simplified reversed chloroquines to overcome malaria resistance to quinoline-based drugs. Antimicrob. Agents Chemother. 61, e01913\u201301916 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1021\/acs.biochem.5b00412","volume":"54","author":"PS Callaghan","year":"2015","unstructured":"Callaghan, P. S., Hassett, M. R. & Roepe, P. D. Functional comparison of 45 naturally occurring isoforms of the Plasmodium falciparum chloroquine resistance transporter (PfCRT). Biochemistry 54, 5083\u20135094 (2015).","journal-title":"Biochemistry"},{"key":"353_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6329","volume":"5","author":"SJ Goldfless","year":"2014","unstructured":"Goldfless, S. J., Wagner, J. C. & Niles, J. C. Versatile control of Plasmodium falciparum gene expression with an inducible protein-RNA interaction. Nat. Commun. 5, 5329 (2014).","journal-title":"Nat. Commun."},{"key":"353_CR10","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/med.21591","volume":"39","author":"A Lamut","year":"2019","unstructured":"Lamut, A., Peterlin Masic, L., Kikelj, D. & Tomasic, T. Efflux pump inhibitors of clinically relevant multidrug resistant bacteria. Med. Res. Rev. 39, 2460\u20132504 (2019).","journal-title":"Med. Res. Rev."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41579-020-0353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41579-020-0353-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41579-020-0353-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:03:26Z","timestamp":1684620206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-020-0353-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1038\/s41579-020-0353-8","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]},"assertion":[{"value":"16 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}